CD14 and rheumatoid arthritis: We observed increased number and percentage of intermediate (CD14++CD16+) monocytes and an increased number of classical (CD14++CD16−) monocytes and a decreased percentage of nonclassical (CD14+CD16++) monocytes in RA patients in comparison with healthy subjects (Figure 1).